Article Details
Retrieved on: 2022-11-24 18:17:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on November 14, 2022, Health Canada has authorized POLIVY® (polatuzumab ...
Article found on: www.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here